Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats

Makoto Katoh, Kensuke Egashira, Chu Kataoka, Makoto Usui, Masamichi Koyanagi, Shiro Kitamoto, Yasushi Ohmachi, Akira Takeshita, Hiroshi Narita

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We previously reported that chronic inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) induces vascular inflammation at week 1 and produces subsequent arteriosclerosis at week 4 and that cotreatment with an angiotensin-converting enzyme (ACE) inhibitor prevents such changes. In the present study, we tested the hypothesis that treatment with an ACE inhibitor after development of vascular inflammation could inhibit arteriosclerosis in rats. Wistar-Kyoto rats were randomized to four groups: the control group received no drugs, the 4WL-NAME group received L-NAME (100 mg·kg-1·day-1) for 4 wk, the 1wL + 3wNT group received L-NAME for 1 wk and no treatment for the subsequent 3 wk, and the 1wL + 3wACEI group received L-NAME for 1 wk and the ACE inhibitor imidapril (20 mg·kg -1· day-1) for the subsequent 3 wk. After 4 wk, we observed significant arteriosclerosis of the coronary artery (medial thickening and fibrosis) and increased cardiac ACE activity in the 1wL + 3wNT group as well as in the 4WL-NAME group, but not in the 1wL + 3wACEI group. In a separate study, we examined apoptosis formation and found that posttreatment with imidapril (20 mg·kg-1·day-1) or an ANG II AT1-receptor antagonist, CS-866 (5 mg·kg-1·day-1), induced apoptosis (TdT-mediated nick end-labeling) in monocytes and myofibroblasts appearing in the inflammatory lesions associated with a clear degradation in the heart (DNA electrophoresis). In conclusion, treatment with the ACE inhibitor after 1 wk of L-NAME administration inhibited arteriosclerosis by inducing apoptosis in the cells with inflammatory lesions in this study, suggesting that increased ANG II activity inhibited apoptosis of the cells with inflammatory lesions and thus contributed to the development of arteriosclerosis.

Original languageEnglish
Pages (from-to)H2306-H2312
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume280
Issue number5 49-5
Publication statusPublished - May 1 2001

Fingerprint

Arteriosclerosis
NG-Nitroarginine Methyl Ester
Peptidyl-Dipeptidase A
Nitric Oxide
Angiotensin-Converting Enzyme Inhibitors
Apoptosis
Blood Vessels
Inflammation
Myofibroblasts
Inbred WKY Rats
Electrophoresis
Monocytes
Coronary Vessels
Fibrosis
Control Groups
DNA
Pharmaceutical Preparations
imidapril

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats. / Katoh, Makoto; Egashira, Kensuke; Kataoka, Chu; Usui, Makoto; Koyanagi, Masamichi; Kitamoto, Shiro; Ohmachi, Yasushi; Takeshita, Akira; Narita, Hiroshi.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 280, No. 5 49-5, 01.05.2001, p. H2306-H2312.

Research output: Contribution to journalArticle

Katoh, M, Egashira, K, Kataoka, C, Usui, M, Koyanagi, M, Kitamoto, S, Ohmachi, Y, Takeshita, A & Narita, H 2001, 'Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats', American Journal of Physiology - Heart and Circulatory Physiology, vol. 280, no. 5 49-5, pp. H2306-H2312.
Katoh, Makoto ; Egashira, Kensuke ; Kataoka, Chu ; Usui, Makoto ; Koyanagi, Masamichi ; Kitamoto, Shiro ; Ohmachi, Yasushi ; Takeshita, Akira ; Narita, Hiroshi. / Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats. In: American Journal of Physiology - Heart and Circulatory Physiology. 2001 ; Vol. 280, No. 5 49-5. pp. H2306-H2312.
@article{98163ed81335489388e23509326f7fbd,
title = "Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats",
abstract = "We previously reported that chronic inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) induces vascular inflammation at week 1 and produces subsequent arteriosclerosis at week 4 and that cotreatment with an angiotensin-converting enzyme (ACE) inhibitor prevents such changes. In the present study, we tested the hypothesis that treatment with an ACE inhibitor after development of vascular inflammation could inhibit arteriosclerosis in rats. Wistar-Kyoto rats were randomized to four groups: the control group received no drugs, the 4WL-NAME group received L-NAME (100 mg·kg-1·day-1) for 4 wk, the 1wL + 3wNT group received L-NAME for 1 wk and no treatment for the subsequent 3 wk, and the 1wL + 3wACEI group received L-NAME for 1 wk and the ACE inhibitor imidapril (20 mg·kg -1· day-1) for the subsequent 3 wk. After 4 wk, we observed significant arteriosclerosis of the coronary artery (medial thickening and fibrosis) and increased cardiac ACE activity in the 1wL + 3wNT group as well as in the 4WL-NAME group, but not in the 1wL + 3wACEI group. In a separate study, we examined apoptosis formation and found that posttreatment with imidapril (20 mg·kg-1·day-1) or an ANG II AT1-receptor antagonist, CS-866 (5 mg·kg-1·day-1), induced apoptosis (TdT-mediated nick end-labeling) in monocytes and myofibroblasts appearing in the inflammatory lesions associated with a clear degradation in the heart (DNA electrophoresis). In conclusion, treatment with the ACE inhibitor after 1 wk of L-NAME administration inhibited arteriosclerosis by inducing apoptosis in the cells with inflammatory lesions in this study, suggesting that increased ANG II activity inhibited apoptosis of the cells with inflammatory lesions and thus contributed to the development of arteriosclerosis.",
author = "Makoto Katoh and Kensuke Egashira and Chu Kataoka and Makoto Usui and Masamichi Koyanagi and Shiro Kitamoto and Yasushi Ohmachi and Akira Takeshita and Hiroshi Narita",
year = "2001",
month = "5",
day = "1",
language = "English",
volume = "280",
pages = "H2306--H2312",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 49-5",

}

TY - JOUR

T1 - Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats

AU - Katoh, Makoto

AU - Egashira, Kensuke

AU - Kataoka, Chu

AU - Usui, Makoto

AU - Koyanagi, Masamichi

AU - Kitamoto, Shiro

AU - Ohmachi, Yasushi

AU - Takeshita, Akira

AU - Narita, Hiroshi

PY - 2001/5/1

Y1 - 2001/5/1

N2 - We previously reported that chronic inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) induces vascular inflammation at week 1 and produces subsequent arteriosclerosis at week 4 and that cotreatment with an angiotensin-converting enzyme (ACE) inhibitor prevents such changes. In the present study, we tested the hypothesis that treatment with an ACE inhibitor after development of vascular inflammation could inhibit arteriosclerosis in rats. Wistar-Kyoto rats were randomized to four groups: the control group received no drugs, the 4WL-NAME group received L-NAME (100 mg·kg-1·day-1) for 4 wk, the 1wL + 3wNT group received L-NAME for 1 wk and no treatment for the subsequent 3 wk, and the 1wL + 3wACEI group received L-NAME for 1 wk and the ACE inhibitor imidapril (20 mg·kg -1· day-1) for the subsequent 3 wk. After 4 wk, we observed significant arteriosclerosis of the coronary artery (medial thickening and fibrosis) and increased cardiac ACE activity in the 1wL + 3wNT group as well as in the 4WL-NAME group, but not in the 1wL + 3wACEI group. In a separate study, we examined apoptosis formation and found that posttreatment with imidapril (20 mg·kg-1·day-1) or an ANG II AT1-receptor antagonist, CS-866 (5 mg·kg-1·day-1), induced apoptosis (TdT-mediated nick end-labeling) in monocytes and myofibroblasts appearing in the inflammatory lesions associated with a clear degradation in the heart (DNA electrophoresis). In conclusion, treatment with the ACE inhibitor after 1 wk of L-NAME administration inhibited arteriosclerosis by inducing apoptosis in the cells with inflammatory lesions in this study, suggesting that increased ANG II activity inhibited apoptosis of the cells with inflammatory lesions and thus contributed to the development of arteriosclerosis.

AB - We previously reported that chronic inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) induces vascular inflammation at week 1 and produces subsequent arteriosclerosis at week 4 and that cotreatment with an angiotensin-converting enzyme (ACE) inhibitor prevents such changes. In the present study, we tested the hypothesis that treatment with an ACE inhibitor after development of vascular inflammation could inhibit arteriosclerosis in rats. Wistar-Kyoto rats were randomized to four groups: the control group received no drugs, the 4WL-NAME group received L-NAME (100 mg·kg-1·day-1) for 4 wk, the 1wL + 3wNT group received L-NAME for 1 wk and no treatment for the subsequent 3 wk, and the 1wL + 3wACEI group received L-NAME for 1 wk and the ACE inhibitor imidapril (20 mg·kg -1· day-1) for the subsequent 3 wk. After 4 wk, we observed significant arteriosclerosis of the coronary artery (medial thickening and fibrosis) and increased cardiac ACE activity in the 1wL + 3wNT group as well as in the 4WL-NAME group, but not in the 1wL + 3wACEI group. In a separate study, we examined apoptosis formation and found that posttreatment with imidapril (20 mg·kg-1·day-1) or an ANG II AT1-receptor antagonist, CS-866 (5 mg·kg-1·day-1), induced apoptosis (TdT-mediated nick end-labeling) in monocytes and myofibroblasts appearing in the inflammatory lesions associated with a clear degradation in the heart (DNA electrophoresis). In conclusion, treatment with the ACE inhibitor after 1 wk of L-NAME administration inhibited arteriosclerosis by inducing apoptosis in the cells with inflammatory lesions in this study, suggesting that increased ANG II activity inhibited apoptosis of the cells with inflammatory lesions and thus contributed to the development of arteriosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=0035026286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035026286&partnerID=8YFLogxK

M3 - Article

C2 - 11299235

AN - SCOPUS:0035026286

VL - 280

SP - H2306-H2312

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 5 49-5

ER -